Your session is about to expire
← Back to Search
Auto Transplant for High-Risk or Relapsed Brain and Solid Cancers
Study Summary
This trial is a standard of care treatment guideline for high risk or relapsed solid tumors or CNS tumors.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My condition is listed as eligible for this trial.My age and physical ability match the study requirements.You need to have had a biopsy to confirm that you have cancer.My cancer has features that make it hard to treat with standard chemo.My cancer is confirmed as a germ cell tumor for treatment group C.My disease status qualifies me for one of the study arms.I do not have an active, uncontrolled infection or HIV.I cannot undergo stem cell collection due to health reasons.My child is 12-18 months old with Stage 4 neuroblastoma and has all favorable features for treatment.My condition qualifies for one of the specific study groups.My organs are functioning well.
- Group 1: Arm C: Germ Cell Tumors
- Group 2: Arm B: Certain CNS Tumors
- Group 3: Arm A: Patients with High Risk or Relapsed Solid Tumor
- Group 4: Arm D: Certain CNS Tumors
- Group 5: Arm E: Neuroblastoma
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
In what conditions does this remedial measure typically prove efficacious?
"As a first-line treatment for acute lymphoblastic leukemia (ALL), this intervention is also effective at controlling metastatic neoplasms, primary biliary cholangitis and both Hodgkin's and non-Hodgkins' lymphoma."
Is this clinical endeavor actively soliciting participants now?
"As documented on clinicaltrials.gov, this experiment is currently seeking participants; being initially posted in October 2011 and updated most recently on April 11th 2022."
How many individuals can register for this trial before it reaches its capacity?
"Affirmative, clinicaltrials.gov showcases that this trial is actively enrolling participants. With its initial posting on October 20th 2011 and most recent edit occurring April 11th 2022, the study requires a total of twenty individuals across one location for completion."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger